Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Brock

Showing results (21-30 of 194) with videos related to

Pageof 20
Sort By:
Cancer|September 15, 1984
Models in cytostatic chemotherapyN Brock, B Schneider
Arzneimittel-Forschung|January 1, 1970
[Pharmacology of isopropylidene-proscillaridin]D Lenke, N Brock
Arzneimittel-Forschung|August 1, 1971
[Immunosuppressive effect of various cytostatics on humoral antibody formation]J Potel, N Brock
Arzneimittel-Forschung|January 1, 1982
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)]N Brock, J Stekar
Cancer Treatment Reviews|March 1, 1984
25 years of oxazaphosphorine researchN Brock, J Pohl
Journal of the American Veterinary Medical Association|September 15, 1991
Erroneous assumptions on use of isofluraneM Holland, N Brock
Cancer Treatment Reviews|September 1, 1983
The development of mesna for regional detoxificationN Brock, J Pohl
Arzneimittel-Forschung|August 1, 1974
Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological actionN Brock, J Kuhlmann
Investigational New Drugs|January 1, 1984
The key role of hydroxylation for the cytostatic activity and selectivity of cyclophosphamideP Hilgard, N Brock
IARC Scientific Publications|January 1, 1986
Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostaticsN Brock, J Pohl
Pageof 20

Showing results (21-30 of 194) with videos related to

Sort By:
Pageof 20
Cancer|September 15, 1984
Models in cytostatic chemotherapyN Brock, B Schneider
Arzneimittel-Forschung|January 1, 1970
[Pharmacology of isopropylidene-proscillaridin]D Lenke, N Brock
Arzneimittel-Forschung|August 1, 1971
[Immunosuppressive effect of various cytostatics on humoral antibody formation]J Potel, N Brock
Arzneimittel-Forschung|January 1, 1982
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)]N Brock, J Stekar
Cancer Treatment Reviews|March 1, 1984
25 years of oxazaphosphorine researchN Brock, J Pohl
Journal of the American Veterinary Medical Association|September 15, 1991
Erroneous assumptions on use of isofluraneM Holland, N Brock
Cancer Treatment Reviews|September 1, 1983
The development of mesna for regional detoxificationN Brock, J Pohl
Arzneimittel-Forschung|August 1, 1974
Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological actionN Brock, J Kuhlmann
Investigational New Drugs|January 1, 1984
The key role of hydroxylation for the cytostatic activity and selectivity of cyclophosphamideP Hilgard, N Brock
IARC Scientific Publications|January 1, 1986
Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostaticsN Brock, J Pohl
Pageof 20